Stoke Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 02/17/2026 | 5.60 M | $177.77 M | -18.41% | 9.56% |
| RTW INVESTMENTS, LP | 02/17/2026 | 5.55 M | $176.06 M | 8.26% | 9.46% |
| LYNX1 CAPITAL MANAGEMENT LP | 02/17/2026 | 5.40 M | $171.54 M | 0.00% | 9.22% |
| BLACKROCK, INC. | 02/12/2026 | 5.21 M | $165.45 M | -12.94% | 8.89% |
| REDMILE GROUP, LLC | 02/17/2026 | 4.03 M | $128.04 M | -3.39% | 6.88% |
| MORGAN STANLEY | 02/13/2026 | 3.55 M | $112.56 M | 0.26% | 6.05% |
| BAKER BROS. ADVISORS LP | 02/17/2026 | 3.34 M | $105.91 M | -27.99% | 5.69% |
| TORONTO DOMINION BANK | 02/17/2026 | 3.17 M | $100.72 M | 0.00% | 5.41% |
| VANGUARD GROUP INC | 01/29/2026 | 3.15 M | $99.96 M | -0.46% | 5.37% |
| STATE STREET CORP | 02/13/2026 | 2.50 M | $79.29 M | 75.19% | 4.26% |
| BVF INC/IL | 02/17/2026 | 2.27 M | $71.91 M | 36.73% | 3.87% |
| SIREN, L.L.C. | 02/13/2026 | 2.25 M | $71.33 M | 0.00% | 3.83% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/17/2026 | 1.82 M | $57.88 M | 100.00% | 3.11% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 1.45 M | $46.03 M | 333.79% | 2.48% |
| POLAR CAPITAL HOLDINGS PLC | 02/17/2026 | 1.27 M | $40.28 M | -4.11% | 2.17% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/09/2026 | 1.23 M | $38.97 M | 36.37% | 2.09% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 1.22 M | $38.79 M | -6.47% | 2.09% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 1.17 M | $37.02 M | 1.67% | 1.99% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 1.14 M | $36.27 M | -0.71% | 1.95% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 827.14 K | $26.25 M | 21.94% | 1.41% |
| BIOIMPACT CAPITAL LLC | 02/17/2026 | 770.29 K | $24.45 M | -2.46% | 1.31% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 735.80 K | $23.35 M | -0.26% | 1.26% |
| OPALEYE MANAGEMENT INC. | 04/13/2026 | 695.00 K | $22.06 M | 1.90% | 1.19% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 502.10 K | $15.94 M | 0.42% | 0.86% |
| TANG CAPITAL MANAGEMENT LLC | 02/17/2026 | 500.00 K | $15.87 M | 0.00% | 0.85% |
| CANDRIAM S.C.A. | 04/30/2026 | 446.69 K | $14.18 M | 100.00% | 0.76% |
| PARKMAN HEALTHCARE PARTNERS LLC | 02/17/2026 | 430.16 K | $13.65 M | 72.06% | 0.73% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 410.91 K | $13.04 M | 1.98% | 0.70% |
| NORTHERN TRUST CORP | 02/17/2026 | 403.17 K | $12.80 M | -2.83% | 0.69% |
| ERSTE ASSET MANAGEMENT GMBH | 02/11/2026 | 396.00 K | $12.60 M | 0.00% | 0.68% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 372.33 K | $11.82 M | 626.32% | 0.64% |
| JPMORGAN CHASE & CO | 02/11/2026 | 277.93 K | $8.82 M | 1,040.18% | 0.47% |
| BIRCHVIEW CAPITAL, LP | 02/13/2026 | 260.00 K | $8.25 M | 23.81% | 0.44% |
| INVESCO LTD. | 02/19/2026 | 259.54 K | $8.24 M | 24.74% | 0.44% |
| BAILLIE GIFFORD & CO | 01/23/2026 | 246.90 K | $7.84 M | 100.00% | 0.42% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 02/13/2026 | 216.00 K | $6.86 M | -13.60% | 0.37% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 206.16 K | $6.54 M | -17.35% | 0.35% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 02/17/2026 | 191.40 K | $6.07 M | -24.62% | 0.33% |
| UBS GROUP AG | 01/29/2026 | 169.71 K | $5.39 M | -44.54% | 0.29% |
| FIRST TRUST ADVISORS LP | 02/13/2026 | 162.68 K | $5.16 M | 6.82% | 0.28% |
| BARCLAYS PLC | 02/13/2026 | 150.95 K | $4.79 M | 40.12% | 0.26% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 140.80 K | $4.47 M | 16.91% | 0.24% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 132.22 K | $4.20 M | 14.15% | 0.23% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 02/17/2026 | 126.35 K | $4.01 M | 0.00% | 0.22% |
| GILDER GAGNON HOWE & CO LLC | 02/17/2026 | 122.45 K | $3.89 M | -21.09% | 0.21% |
| EAM INVESTORS, LLC | 02/12/2026 | 117.82 K | $3.74 M | -1.96% | 0.20% |
| HIGHVISTA STRATEGIES LLC | 02/17/2026 | 115.54 K | $3.67 M | 100.00% | 0.20% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 115.12 K | $3.65 M | 16.17% | 0.20% |
| DAFNA CAPITAL MANAGEMENT LLC | 02/17/2026 | 108.88 K | $3.46 M | -35.88% | 0.19% |
| NUVEEN, LLC | 02/12/2026 | 104.26 K | $3.31 M | -1.64% | 0.18% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Stoke Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 208 institutional investors and hedge funds held shares of Stoke Therapeutics Inc. The most heavily invested institutionals were:
Lynx1 Capital Management LP: 4.76 M
Assenagon Asset Management S.A.: 907,015
Candriam S.C.A.: 502,020
Nuveen, LLC: 108,617
PRINCIPAL FINANCIAL GROUP INC: 63,933
Moran Wealth Management, LLC: 40,552
114.28% of Stoke Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 94.35 M shares in the last 24 months. This purchase volume represents approximately $3.61 B in transactions.